Short Course Daratumumab in Patients With Multiple Myeloma
Clinical trial NCT03490344 · COMPLETED
Trial details
- NCT number
- NCT03490344
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-03
- Primary completion
- 2023-03-23
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.